| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| 5.892.356.980 $ | 99,77 | 149.921.668 | |||||||
| ELI LILLY & COMPANY | ELI LILLY & COMPANY COM | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 725.598.250 $ | 12,29 | 656.650 | |
| JOHNSON & JOHNSON | JOHNSON & JOHNSON COM | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 518.082.116 $ | 8,77 | 2.299.215 | |
| UNITEDHEALTH GROUP INC | UNITEDHEALTH GROUP INC COM | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 360.310.258 $ | 6,10 | 947.412 | |
| MERCK & COMPANY INC | MERCK & COMPANY INC COM | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 291.631.644 $ | 4,94 | 2.456.466 | |
| GILEAD SCIENCES INC | GILEAD SCIENCES INC COM | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 247.530.395 $ | 4,19 | 1.841.333 | |
| ABBVIE INC | ABBVIE INC COM | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 232.529.097 $ | 3,94 | 1.068.019 | |
| AMGEN INC | AMGEN INC COM | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 198.774.468 $ | 3,37 | 590.203 | |
| THERMO FISHER SCIENTIFIC INC | THERMO FISHER SCIENTIFIC INC COM | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 178.454.596 $ | 3,02 | 362.337 | |
| VERTEX PHARMACEUTICALS INC | VERTEX PHARMACEUTICALS INC COM | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 161.967.859 $ | 2,74 | 361.907 | |
| PFIZER INC | PFIZER INC COM | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 154.436.291 $ | 2,61 | 5.899.018 | |
| EDWARDS LIFESCIENCES CORP | EDWARDS LIFESCIENCES CORP COM | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 147.948.008 $ | 2,51 | 1.710.975 | |
| DANAHER CORP | DANAHER CORP COM | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 117.847.358 $ | 2,00 | 645.138 | |
| ABBOTT LABORATORIES | ABBOTT LABORATORIES COM | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 116.578.126 $ | 1,97 | 1.361.894 | |
| INTUITIVE SURGICAL INC | INTUITIVE SURGICAL INC COM NEW | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 115.260.884 $ | 1,95 | 271.432 | |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA PHARMACEUTICAL INDUSTRIES LTD SPONSORED ADS | EC | 881624209 | Long | Börsenkurs (Stufe 1) | 110.245.693 $ | 1,87 | 3.121.339 | |
| BOSTON SCIENTIFIC CORP | BOSTON SCIENTIFIC CORP COM | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 93.964.496 $ | 1,59 | 1.945.032 | |
| ELEVANCE HEALTH INC | ELEVANCE HEALTH INC COM | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 92.378.811 $ | 1,56 | 234.947 | |
| ARGENX SE | ARGENX SE SPONSORED ADR | EC | 04016X101 | Long | Börsenkurs (Stufe 1) | 74.398.930 $ | 1,26 | 88.995 | |
| BIOGEN INC | BIOGEN INC COM | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 71.380.848 $ | 1,21 | 364.188 | |
| ASTRAZENECA PLC | ASTRAZENECA PLC ORD USD0.25 | EC | GB0009895292 | Long | Modellwert (Stufe 2) | 71.361.126 $ | 1,21 | 384.355 | |
| STRYKER CORP | STRYKER CORP COM | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 67.714.115 $ | 1,15 | 221.948 | |
| REVOLUTION MEDICINES INC | REVOLUTION MEDICINES INC COM | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 56.903.823 $ | 0,96 | 361.340 | |
| HUMANA INC | HUMANA INC COM | EC | 444859102 | Long | Börsenkurs (Stufe 1) | 54.427.371 $ | 0,92 | 178.205 | |
| REGENERON PHARMACEUTICALS INC | REGENERON PHARMACEUTICALS INC COM | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 53.891.000 $ | 0,91 | 87.659 | |
| BRISTOL-MYERS SQUIBB COMPANY | BRISTOL-MYERS SQUIBB COMPANY COM | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 52.435.547 $ | 0,89 | 917.026 | |
| COGENT BIOSCIENCES INC | COGENT BIOSCIENCES INC COM | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 49.183.756 $ | 0,83 | 1.406.858 | |
| DEXCOM INC | DEXCOM INC COM | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 48.946.326 $ | 0,83 | 663.769 | |
| WATERS CORP | WATERS CORP COM | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 47.734.903 $ | 0,81 | 124.449 | |
| CYTOKINETICS INC | CYTOKINETICS INC COM NEW | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 44.151.431 $ | 0,75 | 575.188 | |
| PENUMBRA INC | PENUMBRA INC COM | EC | 70975L107 | Long | Börsenkurs (Stufe 1) | 42.402.653 $ | 0,72 | 133.216 | |
| HCA HEALTHCARE INC | HCA HEALTHCARE INC COM | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 42.255.285 $ | 0,72 | 111.627 | |
| INSMED INC | INSMED INC COM PAR $.01 | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 41.924.650 $ | 0,71 | 392.149 | |
| CVS HEALTH CORP | CVS HEALTH CORP COM | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 41.823.961 $ | 0,71 | 459.705 | |
| RHYTHM PHARMACEUTICALS INC | RHYTHM PHARMACEUTICALS INC COM | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 41.623.096 $ | 0,70 | 471.276 | |
| GALDERMA GROUP AG | GALDERMA GROUP AG CHF0.01 | EC | CH1335392721 | Long | Modellwert (Stufe 2) | 39.790.711 $ | 0,67 | 188.090 | |
| INCYTE CORP | INCYTE CORP COM | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 38.325.873 $ | 0,65 | 396.174 | |
| NOVARTIS AG | NOVARTIS AG SPONSORED ADR | EC | 66987V109 | Long | Börsenkurs (Stufe 1) | 37.791.782 $ | 0,64 | 251.660 | |
| PROTAGONIST THERAPEUTICS INC | PROTAGONIST THERAPEUTICS INC COM | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 36.877.820 $ | 0,62 | 370.408 | |
| AGILENT TECHNOLOGIES INC | AGILENT TECHNOLOGIES INC COM | EC | 00846U101 | Long | Börsenkurs (Stufe 1) | 36.761.022 $ | 0,62 | 271.239 | |
| IDEXX LABORATORIES INC | IDEXX LABORATORIES INC COM | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 36.686.930 $ | 0,62 | 65.102 | |
| NUVALENT INC | NUVALENT INC COM | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 34.865.688 $ | 0,59 | 315.841 | |
| UNITED THERAPEUTICS CORP | UNITED THERAPEUTICS CORP COM | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 31.008.749 $ | 0,53 | 55.689 | |
| ALNYLAM PHARMACEUTICALS INC | ALNYLAM PHARMACEUTICALS INC COM | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 28.661.828 $ | 0,49 | 94.913 | |
| BRUKER CORP | BRUKER CORP COM | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 27.793.077 $ | 0,47 | 471.949 | |
| MODERNA INC | MODERNA INC COM | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 26.464.105 $ | 0,45 | 560.799 | |
| IQVIA HOLDINGS INC | IQVIA HOLDINGS INC COM | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 25.726.230 $ | 0,44 | 141.190 | |
| ILLUMINA INC | ILLUMINA INC COM | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 23.781.242 $ | 0,40 | 145.933 | |
| MEDLINE INC | MEDLINE INC COM CL A | EC | 58507V107 | Long | Börsenkurs (Stufe 1) | 22.124.247 $ | 0,37 | 605.149 | |
| APOGEE THERAPEUTICS INC | APOGEE THERAPEUTICS INC COM | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 21.660.482 $ | 0,37 | 263.702 | |
| MCKESSON CORP | MCKESSON CORP COM | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 20.480.950 $ | 0,35 | 27.586 | |
| BIOMARIN PHARMACEUTICAL INC | BIOMARIN PHARMACEUTICAL INC COM | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 18.483.759 $ | 0,31 | 322.635 | |
| NEUROCRINE BIOSCIENCES INC | NEUROCRINE BIOSCIENCES INC COM | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 17.888.692 $ | 0,30 | 113.005 | |
| DIANTHUS THERAPEUTICS INC | DIANTHUS THERAPEUTICS INC COM | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 17.344.691 $ | 0,29 | 186.482 | |
| ROIVANT SCIENCES LTD | ROIVANT SCIENCES LTD SHS | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 16.910.011 $ | 0,29 | 563.855 | |
| QUEST DIAGNOSTICS INC | QUEST DIAGNOSTICS INC COM | EC | 74834L100 | Long | Börsenkurs (Stufe 1) | 16.604.116 $ | 0,28 | 85.193 | |
| LB PHARMACEUTICALS INC | LB PHARMACEUTICALS INC COM SHS | EC | 50180M108 | Long | Börsenkurs (Stufe 1) | 15.876.527 $ | 0,27 | 567.627 | |
| UCB SA | UCB SA NPV | EC | BE0003739530 | Long | Modellwert (Stufe 2) | 15.731.634 $ | 0,27 | 53.577 | |
| ORUKA THERAPEUTICS INC | ORUKA THERAPEUTICS INC COM | EC | 687604108 | Long | Börsenkurs (Stufe 1) | 15.499.505 $ | 0,26 | 264.813 | |
| STOKE THERAPEUTICS INC | STOKE THERAPEUTICS INC COM | EC | 86150R107 | Long | Börsenkurs (Stufe 1) | 14.625.128 $ | 0,25 | 473.152 | |
| ARCUS BIOSCIENCES INC | ARCUS BIOSCIENCES INC COM | EC | 03969F109 | Long | Börsenkurs (Stufe 1) | 14.505.376 $ | 0,25 | 572.430 | |
| MADRIGAL PHARMACEUTICALS INC | MADRIGAL PHARMACEUTICALS INC COM | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 13.718.685 $ | 0,23 | 27.588 | |
| IONIS PHARMACEUTICALS INC | IONIS PHARMACEUTICALS INC COM | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 13.005.612 $ | 0,22 | 170.008 | |
| CENCORA INC | CENCORA INC COM | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 12.474.062 $ | 0,21 | 46.310 | |
| EXELIXIS INC | EXELIXIS INC COM | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 11.693.793 $ | 0,20 | 231.652 | |
| ELANCO ANIMAL HEALTH INC | ELANCO ANIMAL HEALTH INC COM | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 11.525.489 $ | 0,20 | 483.249 | |
| DAIICHI SANKYO COMPANY LTD | DAIICHI SANKYO COMPANY LTD NPV | EC | JP3475350009 | Long | Modellwert (Stufe 2) | 11.340.422 $ | 0,19 | 673.800 | |
| SCHOLAR ROCK HOLDING CORP | SCHOLAR ROCK HOLDING CORP COM | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 11.152.104 $ | 0,19 | 226.209 | |
| ADARX PHARMACEUTICALS INC | ADARX PHARMACEUTICALS INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 10.892.297 $ | 0,18 | 769.230 | |
| KAILERA THERAPEUTICS INC | KAILERA THERAPEUTICS INC COMMON STOCK | EC | 482931102 | Long | Börsenkurs (Stufe 1) | 20.466.472 $ | 0,35 | 892.174 | |
| WEST PHARMACEUTICAL SERVICES INC | WEST PHARMACEUTICAL SERVICES INC COM | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 10.496.813 $ | 0,18 | 32.517 | |
| MBX BIOSCIENCES INC | MBX BIOSCIENCES INC COM | EC | 55287L101 | Long | Börsenkurs (Stufe 1) | 10.490.525 $ | 0,18 | 333.350 | |
| NATERA INC | NATERA INC COM | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 10.317.460 $ | 0,17 | 46.190 | |
| CHARLES RIVER LABORATORIES INTERNATIONAL INC | CHARLES RIVER LABORATORIES INTERNATIONAL INC COM | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 10.151.746 $ | 0,17 | 56.177 | |
| BIO-TECHNE CORP | BIO-TECHNE CORP COM | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 10.022.044 $ | 0,17 | 193.925 | |
| NOVOCURE LTD | NOVOCURE LTD COM USD0.00 | EC | JE00BYSS4X48 | Long | Börsenkurs (Stufe 1) | 9.785.987 $ | 0,17 | 574.295 | |
| INTELLIA THERAPEUTICS INC | INTELLIA THERAPEUTICS INC COM | EC | 45826J105 | Long | Börsenkurs (Stufe 1) | 9.354.383 $ | 0,16 | 664.846 | |
| ERASCA INC | ERASCA INC COM | EC | 29479A108 | Long | Börsenkurs (Stufe 1) | 9.114.654 $ | 0,15 | 709.864 | |
| VIRIDIAN THERAPEUTICS INC | VIRIDIAN THERAPEUTICS INC COM | EC | 92790C104 | Long | Börsenkurs (Stufe 1) | 9.093.594 $ | 0,15 | 516.095 | |
| GLAUKOS CORP | GLAUKOS CORP COM | EC | 377322102 | Long | Börsenkurs (Stufe 1) | 9.006.953 $ | 0,15 | 87.150 | |
| AXSOME THERAPEUTICS INC | AXSOME THERAPEUTICS INC COM | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 8.951.977 $ | 0,15 | 38.178 | |
| BRIGHT MINDS BIOSCIENCES INC | BRIGHT MINDS BIOSCIENCES INC COM NEW | EC | 10919W405 | Long | Börsenkurs (Stufe 1) | 8.424.336 $ | 0,14 | 95.655 | |
| AGIOS PHARMACEUTICALS INC | AGIOS PHARMACEUTICALS INC COM | EC | 00847X104 | Long | Börsenkurs (Stufe 1) | 7.985.481 $ | 0,14 | 271.615 | |
| EIKON THERAPEUTICS INC | EIKON THERAPEUTICS INC COM | EC | 282564103 | Long | Börsenkurs (Stufe 1) | 7.830.697 $ | 0,13 | 722.389 | |
| VAXCYTE INC | VAXCYTE INC COM | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 7.573.893 $ | 0,13 | 147.352 | |
| LARONDE INC | LARONDE INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 7.467.566 $ | 0,13 | 386.520 | |
| METTLER-TOLEDO INTERNATIONAL INC | METTLER-TOLEDO INTERNATIONAL INC COM | EC | 592688105 | Long | Börsenkurs (Stufe 1) | 7.151.954 $ | 0,12 | 6.058 | |
| KARTOS THERAPEUTICS INC | KARTOS THERAPEUTICS INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 9.541.094 $ | 0,16 | 2.187.771 | |
| Angitia Biopharmaceuticals Limited | Angitia Biopharmaceuticals Limited | EC | Long | Schätzwert (Stufe 3) | beschränkt | 6.517.075 $ | 0,11 | 658.956 | |
| ENANTA PHARMACEUTICALS INC | ENANTA PHARMACEUTICALS INC COM | EC | 29251M106 | Long | Börsenkurs (Stufe 1) | 6.474.733 $ | 0,11 | 492.001 | |
| ALUMIS INC | ALUMIS INC COM | EC | 022307102 | Long | Börsenkurs (Stufe 1) | 6.343.099 $ | 0,11 | 293.662 | |
| IMMUNOME INC | IMMUNOME INC COM | EC | 45257U108 | Long | Börsenkurs (Stufe 1) | 6.304.329 $ | 0,11 | 288.792 | |
| MONTE ROSA THERAPEUTICS INC | MONTE ROSA THERAPEUTICS INC COM | EC | 61225M102 | Long | Börsenkurs (Stufe 1) | 6.270.973 $ | 0,11 | 318.162 | |
| GENESIS THERAPEUTICS INC | GENESIS THERAPEUTICS INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 6.088.399 $ | 0,10 | 823.870 | |
| BRIDGEBIO ONCOLOGY THERAPEUTICS INC | BRIDGEBIO ONCOLOGY THERAPEUTICS INC COM NEW | EC | 107924102 | Long | Börsenkurs (Stufe 1) | 7.920.985 $ | 0,13 | 883.053 | |
| PALVELLA THERAPEUTICS INC | PALVELLA THERAPEUTICS INC COM | EC | 697947109 | Long | Börsenkurs (Stufe 1) | 6.007.817 $ | 0,10 | 50.716 | |
| RADNET INC | RADNET INC COM | EC | 750491102 | Long | Börsenkurs (Stufe 1) | 6.002.793 $ | 0,10 | 108.100 | |
| BRIDGEBIO PHARMA INC | BRIDGEBIO PHARMA INC COM | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 5.762.500 $ | 0,10 | 86.968 | |
| KALVISTA PHARMACEUTICALS INC | KALVISTA PHARMACEUTICALS INC COM | EC | 483497103 | Long | Börsenkurs (Stufe 1) | 5.712.213 $ | 0,10 | 212.587 | |
| BEAM THERAPEUTICS INC | BEAM THERAPEUTICS INC COM | EC | 07373V105 | Long | Börsenkurs (Stufe 1) | 5.532.569 $ | 0,09 | 168.010 | |
| AKTIS ONCOLOGY INC | AKTIS ONCOLOGY INC COM | EC | 01021M104 | Long | Börsenkurs (Stufe 1) | 5.527.272 $ | 0,09 | 266.503 | |
| IMMUNOCORE HOLDINGS PLC | IMMUNOCORE HOLDINGS PLC ADS | EC | 45258D105 | Long | Börsenkurs (Stufe 1) | 5.451.283 $ | 0,09 | 188.691 | |
| DYNE THERAPEUTICS INC | DYNE THERAPEUTICS INC COM | EC | 26818M108 | Long | Börsenkurs (Stufe 1) | 5.391.794 $ | 0,09 | 278.934 | |
| DENALI THERAPEUTICS INC | DENALI THERAPEUTICS INC COM | EC | 24823R105 | Long | Börsenkurs (Stufe 1) | 5.299.113 $ | 0,09 | 251.859 | |
| MAZE THERAPEUTICS INC | MAZE THERAPEUTICS INC COM | EC | 578784100 | Long | Börsenkurs (Stufe 1) | 4.880.626 $ | 0,08 | 184.453 | |
| SUMMIT THERAPEUTICS INC | SUMMIT THERAPEUTICS INC COM | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 4.858.352 $ | 0,08 | 276.987 | |
| RELAY THERAPEUTICS INC | RELAY THERAPEUTICS INC COM | EC | 75943R102 | Long | Börsenkurs (Stufe 1) | 4.818.546 $ | 0,08 | 342.957 | |
| AVALO THERAPEUTICS INC | AVALO THERAPEUTICS INC COM NEW | EC | 05338F306 | Long | Börsenkurs (Stufe 1) | 4.778.381 $ | 0,08 | 299.585 | |
| KODIAK SCIENCES INC | KODIAK SCIENCES INC COM | EC | 50015M109 | Long | Börsenkurs (Stufe 1) | 4.722.631 $ | 0,08 | 128.647 | |
| KYMERA THERAPEUTICS INC | KYMERA THERAPEUTICS INC COM | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 4.410.766 $ | 0,07 | 54.173 | |
| ALCON AG | ALCON AG CHF0.04 | EC | CH0432492467 | Long | Börsenkurs (Stufe 1) | 4.345.508 $ | 0,07 | 65.553 | |
| SAGIMET BIOSCIENCES INC | SAGIMET BIOSCIENCES INC COM SER A | EC | 786700104 | Long | Börsenkurs (Stufe 1) | 4.265.969 $ | 0,07 | 585.181 | |
| BIONTECH SE | BIONTECH SE SPONSORED ADS | EC | 09075V102 | Long | Börsenkurs (Stufe 1) | 4.022.320 $ | 0,07 | 41.921 | |
| INSITRO INC | INSITRO INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.964.735 $ | 0,07 | 592.636 | |
| BIOHAVEN LTD | BIOHAVEN LTD COM | EC | VGG1110E1079 | Long | Börsenkurs (Stufe 1) | 3.840.640 $ | 0,07 | 348.832 | |
| ZEALAND PHARMA A/S | ZEALAND PHARMA A/S DKK1 | EC | DK0060257814 | Long | Modellwert (Stufe 2) | 3.753.815 $ | 0,06 | 74.091 | |
| PTC THERAPEUTICS INC | PTC THERAPEUTICS INC COM | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 3.615.253 $ | 0,06 | 48.954 | |
| BICARA THERAPEUTICS INC | BICARA THERAPEUTICS INC COM | EC | 055477103 | Long | Börsenkurs (Stufe 1) | 3.482.262 $ | 0,06 | 160.104 | |
| QUANTA DIALYSIS TECHNOLOGIES LTD | QUANTA DIALYSIS TECHNOLOGIES LTD | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.448.605 $ | 0,06 | 80.024.425 | |
| ULTRAGENYX PHARMACEUTICAL INC | ULTRAGENYX PHARMACEUTICAL INC COM | EC | 90400D108 | Long | Börsenkurs (Stufe 1) | 3.132.669 $ | 0,05 | 130.855 | |
| MOONLAKE IMMUNOTHERAPEUTICS | MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | EC | 61559X104 | Long | Börsenkurs (Stufe 1) | 3.095.479 $ | 0,05 | 161.391 | |
| UPSTREAM BIO INC | UPSTREAM BIO INC COM | EC | 91678A107 | Long | Börsenkurs (Stufe 1) | 2.856.403 $ | 0,05 | 341.675 | |
| ALLOGENE THERAPEUTICS INC | ALLOGENE THERAPEUTICS INC COM | EC | 019770106 | Long | Börsenkurs (Stufe 1) | 2.623.231 $ | 0,04 | 1.208.862 | |
| EYEPOINT INC | EYEPOINT INC COM NEW | EC | 30233G209 | Long | Börsenkurs (Stufe 1) | 2.532.371 $ | 0,04 | 186.478 | |
| OCULAR THERAPEUTIX INC | OCULAR THERAPEUTIX INC COM | EC | 67576A100 | Long | Börsenkurs (Stufe 1) | 2.331.617 $ | 0,04 | 258.781 | |
| WAVE LIFE SCIENCES LTD | WAVE LIFE SCIENCES LTD COM NPV | EC | SG9999014716 | Long | Börsenkurs (Stufe 1) | 2.275.904 $ | 0,04 | 345.882 | |
| DEFINIUM THERAPEUTICS INC | DEFINIUM THERAPEUTICS INC COM SHS | EC | 24477V105 | Long | Börsenkurs (Stufe 1) | 1.965.800 $ | 0,03 | 81.265 | |
| VOR BIOPHARMA INC | VOR BIOPHARMA INC COM NEW | EC | 929033207 | Long | Börsenkurs (Stufe 1) | 1.722.718 $ | 0,03 | 115.078 | |
| REGENXBIO INC | REGENXBIO INC COM | EC | 75901B107 | Long | Börsenkurs (Stufe 1) | 1.504.788 $ | 0,03 | 214.663 | |
| MAPLIGHT THERAPEUTICS INC | MAPLIGHT THERAPEUTICS INC COM | EC | 56565P103 | Long | Börsenkurs (Stufe 1) | 1.473.033 $ | 0,02 | 50.257 | |
| CORVUS PHARMACEUTICALS INC | CORVUS PHARMACEUTICALS INC COM | EC | 221015100 | Long | Börsenkurs (Stufe 1) | 1.370.362 $ | 0,02 | 110.424 | |
| 4D MOLECULAR THERAPEUTICS INC | 4D MOLECULAR THERAPEUTICS INC COM | EC | 35104E100 | Long | Börsenkurs (Stufe 1) | 1.251.375 $ | 0,02 | 126.274 | |
| SYNDAX PHARMACEUTICALS INC | SYNDAX PHARMACEUTICALS INC COM | EC | 87164F105 | Long | Börsenkurs (Stufe 1) | 1.147.190 $ | 0,02 | 58.560 | |
| ANNEXON INC | ANNEXON INC COM | EC | 03589W102 | Long | Börsenkurs (Stufe 1) | 1.022.272 $ | 0,02 | 188.611 | |
| NYXOAH SA | NYXOAH SA NPV | EC | BE0974358906 | Long | Börsenkurs (Stufe 1) | 1.005.330 $ | 0,02 | 337.359 | |
| GOLDFINCH BIO INC | GOLDFINCH BIO INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 934.606 $ | 0,02 | 3.115.353 | |
| ORCHESTRA BIOMED HOLDINGS INC | ORCHESTRA BIOMED HOLDINGS INC COM | EC | 68572M106 | Long | Börsenkurs (Stufe 1) | 805.968 $ | 0,01 | 206.130 | |
| EXO IMAGING INC | EXO IMAGING INC | EP | Long | Schätzwert (Stufe 3) | beschränkt | 666.310 $ | 0,01 | 909.960 | |
| CELLARITY INC | CELLARITY INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 497.833 $ | 0,01 | 858.333 | |
| AFFINIVAX INC | AFFINIVAX INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 449.536 $ | 0,01 | 122.824 | |
| BLUEPRINT MEDICINES CORP | BLUEPRINT MEDICINES CORP NPV | EC | 096CVR048 | Long | Schätzwert (Stufe 3) | 202.860 $ | 0,00 | 204.909 | |
| MIRATI THERAPEUTICS INC | MIRATI THERAPEUTICS INC | EC | 604CVR027 | Long | Schätzwert (Stufe 3) | 180.523 $ | 0,00 | 228.510 | |
| GOSSAMER BIO INC | GOSSAMER BIO INC COM | EC | 38341P102 | Long | Börsenkurs (Stufe 1) | 84.324 $ | 0,00 | 365.199 | |
| ARCELLX INC | ARCELLX INC COMMON STOCK | EC | 03940C100 | Long | Modellwert (Stufe 2) | 6.507 $ | 0,00 | 92.964 | |
| SWIFT HEALTH SYSTEMS INC | SWIFT HEALTH SYSTEMS INC | EC | Long | Schätzwert (Stufe 3) | beschränkt | 3.791 $ | 0,00 | 1.700 | |
| HOLOGIC INC | HOLOGIC INC | EC | 436CVR021 | Long | Modellwert (Stufe 2) | 1.384 $ | 0,00 | 138.368 | |
| FREQUENCY THERAPEUTICS CVR | FREQUENCY THERAPEUTICS CVR | EC | Long | Schätzwert (Stufe 3) | 4 $ | 0,00 | 428.010 | ||
| 5.892.356.980 $ | 99,77 | 149.921.668 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
SEC-Meldungen und stellen keine Bewertung oder Empfehlung zu einzelnen Wertpapieren,
Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher SEC-Meldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.